Ascending single dose study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of PRA-027 administered orally to healthy Japanese females.
Phase of Trial: Phase I
Latest Information Update: 14 Jul 2009
At a glance
- Drugs PRA 027 (Primary)
- Indications Uterine leiomyoma
- Focus Adverse reactions
- 14 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 19 Jun 2007 Status changed from initiated to recruiting.
- 02 May 2007 New trial record.